search tools

Mid North Coast Local Area Command launches 'Dob in a Dealer' as state-wide campaign continues (NSW Police Force)

Edit Public Technologies 18 Jul 2016
These will also highlight the important role members of the public have in helping police shut down drug-manufacturing syndicates and arrest drug suppliers ... If you think you have information about someone in your community who is manufacturing or supplying drugs, call Crime Stoppers on 1800 333 000 for a confidential conversation or report securely online at www.crimestoppers.com.au....

Police urge community to show support for 'Dob in a Dealer' as cross-border campaign continues in Albury, Wodonga (NSW Police Force)

Edit Public Technologies 18 Jul 2016
It will run in each LAC for two weeks, during which local residents will be urged to help police shut down drug-manufacturing syndicates and arrest drug suppliers by reporting relevant information to Crime Stoppers ... 'We are focused on targeting the manufacturers and suppliers of 'ice' who continue to distribute dangerous drugs across our community....

2-year investigation leads to drug charges against Riverside man

Edit Chicago Sun-Times 18 Jul 2016
Dokousian, 22, has been charged with manufacture and delivery of cannabis and possession of cannabis, both felonies, according to a statement from Riverside police. He also faces misdemeanor charges of possession of drug paraphernalia and resisting arrest ... Dokousian, whose criminal history includes theft, drugs and assault was also arrested in October 2015 by Elmwood Park police for the manufacture and delivery of cannabis....

Client Alert (Morris, Manning & Martin LLP)

Edit Public Technologies 18 Jul 2016
The biopharmaceutical industry makes frequent use of third-party manufacturing entities, often referred to as contract manufacturing organizations or CMOs, to produce drug product both during development and for post-approval sales ... Batches of the active ingredient were manufactured by for TMC by a third-party more than one year prior to the filing of the patents....

Sun Pharma gets epilepsy drug licence for US market

Edit Yahoo Daily News 18 Jul 2016
Chennai, July 18 (IANS) Sun Pharmaceutical group on Monday announced the licensing of ELEPSIA XR drug by Sun Pharma Advanced Research Company Ltd (SPARC) to a subsidiary of Sun Pharmaceutical Industries Ltd for the US market ... According to Sun Pharma, ELEPSIA-XR was approved by US Food and Drug Administration (USFDA) in March 2015....

Alexion expansion moving forward

Edit The Providence Journal 18 Jul 2016
— Alexion Pharmaceuticals executives and Governor Raimondo expect to gather Monday for a groundbreaking ceremony as the global drug manufacturer embarks on a $200-million expansion of its manufacturing facility here.The company is investing $84 million in the first phase and expects to create 400 local construction jobs over the five-year ......

ICU Medical, Inc. Announces Time of Second Quarter 2016 Earnings Call

Edit Stockhouse 18 Jul 2016
(Nasdaq.ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its second quarter 2016 earnings release and conference call ... (Nasdaq.ICUI) develops, manufactures and sells innovative medical technologies used in infusion therapy, oncology, and critical care applications....

Provectus Biopharmaceuticals Receives Patent Allowance for Use of Halogenated Xanthenes in Pharmaceutical Compositions and as Medicaments

Edit Stockhouse 18 Jul 2016
our intellectual property and our control of the drug supply chain ... 9,273,022, which extends the scope of protection of the manufacturing process conferred by our September 2013 patent to include coverage of the use of alternative raw material in manufacturing halogenated xanthenes, including rose bengal, the active pharmaceutical ingredient (API) in PV-10....

Provectus Biopharmaceuticals Receives Patent Allowance for Use of Halogenated Xanthenes in Pharmaceutical Compositions and as Medicaments (Provectus Pharmaceuticals Inc)

Edit Public Technologies 18 Jul 2016
our intellectual property and our control of the drug supply chain ... 9,273,022, which extends the scope of protection of the manufacturing process conferred by our September 2013 patent to include coverage of the use of alternative raw material in manufacturing halogenated xanthenes, including rose bengal, the active pharmaceutical ingredient (API) in PV-10....

Medication costs likely to jump this year (University of Illinois at Chicago)

Edit Public Technologies 18 Jul 2016
Prescription medication costs are expected to rise at least 11 percent, and possibly up to 13 percent, in 2016, according to a new report on national trends and projections in prescription drug expenditures ... One factor that could inhibit the rising cost of drugs is the introduction of 'biosimilars' - biologic products that are nearly identical to an original product that is manufactured by a different company....

Roadside Drug Tests Routinely Produce False Positives, ProPublica Reports (EJI - Equal Justice Initiative)

Edit Public Technologies 18 Jul 2016
Every year, tens of thousands of people are sent to jail based on the results of an unreliable, $2 drug test, a ProPublica investigation found. In an investigative report published this month, ProPublica details the problems with field tests which, despite their widely acknowledged unreliability, nonetheless provide the sole evidence for tens of thousands of drug convictions in America each year....

ANI Pharmaceuticals Announces FDA Approval and Immediate Launch of Nilutamide Tablets, the First Generic Competitor to Nilandron® (ANI Pharmaceuticals Inc)

Edit Public Technologies 18 Jul 2016
Food and Drug Administration ('FDA') of the Abbreviated New Drug Application ('ANDA') for nilutamide tablets ... We are excited to have secured approval for a first-to-market generic that represents ANI's second entry into the anti-cancer market and leverages our specialized high-potent manufacturing capability at our plant in Baudette, MN....

Cipla Announces Africa Expansion Strategy During International AIDS Conference (Cipla Medpro South Africa Limited)

Edit Public Technologies 18 Jul 2016
Cipla Limited today announced that negotiations to establish manufacturing facilities in Morocco and later in Algeria are in advanced stages of discussion. The pharmaceutical aims to establish these facilities through joint ventures, thereby increasing its antiretroviral (ARV) manufacturing capacity in Africa ... 'These ARVs are produced by Cipla Medpro Manufacturing (CMM), based in KwaZulu-Natal and Cipla Quality Chemical Industries Ltd....
×
×
×
×